Advertising
Showing 1 to 15 of 161 entries
HOLD
Raw costs are going up and has problems with ground water (https://www.bloomberg.com/graphics/2018-3M-groundwater-pollution-problem/). Don't abandon it. Fine to own right here.
mngmnt / diversified

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
TOP PICK
Stockchase Research Editor: Michael O'Reilly We reiterate MMM as a TOP PICK. The company has benefited, and will likely continue to for a while longer, with the N95 mask manufacturing during the pandemic. It trades at values equivalent to its peers at 17x earnings. It pays a solid dividend backed by a payout ratio of under 60% of cash flow. The company continues to build cash reserves, while paying down debt. We would buy this with a stop loss at $165, looking to achieve $205 -- upside potential over 16%. Yield 3.36% (Analysts’ price target is $200.26)
mngmnt / diversified
DON'T BUY
Many other industrials are positioned better. 3M has been struggling for a direction. Profit growth and revenue growth are slow, and they face litigation risk with PFAS. Avoid.
mngmnt / diversified

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
PAST TOP PICK
(A Top Pick Sep 24/20, Up 14.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MMM has achieved its $185 objective. To be disciplined, we recommend removing 50% of the position. We also recommend trailing up the stop to $165. This would all but guarantee a minimum return exceeding 8%.
mngmnt / diversified
COMMENT
A past pick from summer 2020 when we started turning the corner on the pandemic He picked 11 stocks that would soar once we got vaccinations, and this is one of two that did not. 3M soared in late-November 2020, but lost momentum, then lost all gains. Problem is 3M has serious legacy issues, including huge environmental problems. Management failed to solve those. 3M reports next Tuesday. He expects another good report like the last one.
mngmnt / diversified
SELL

Fits and starts. Some issues in revenue growth. Has done well more on the back of a trend in the sector. Litigation re carcinogens, and need to be quite careful with that. His favourite in the space is Raytheon, in aerospace and defence. RTX is undervalued and should do well.

mngmnt / diversified
COMMENT
The manufacturing sector has run up because there are few American industrial stocks. Pays a fine 3.5% dividend, down nearly 4% YTD, held back by possible pollution lawsuits. This will likely do better if Trump wins, who doesn't care about the environment. Though, 3M has a lot of China exposure. Overall, a high-quality company.
mngmnt / diversified

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
TOP PICK
Stockchase Research Editor: Michael O'Reilly We are being rewarded for our patience and are making MMM a Top Pick following a recent pullback in the stock. As previously reported, the maker of the N95 masks has been in the spot light as they have directly been keeping front line workers safer during the pandemic. For 2020 they expect to have produced 2 billion of the masks and continue to partner with the US Department of Defense. The company is mulling over selling the food safety business for $3.5 billion -- 10 times annual revenues of the segment. The segment contributed 1% of total sales in 2019. Their health care segment is expected to pick up as well, after seeing a 12% yoy slowdown, as delays in elective procedures are removed. It has an attractive yield that is backed by a payout ratio of 65% of cash flow. We look for this to test $185 and would use $149 as a stop-loss. Yield 3.69% (Analysts’ price target is $166.47)
mngmnt / diversified

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
BUY on WEAKNESS
Stockchase Research Editor: Michael O'Reilly The maker of the N95 masks has been in the spot light as they have directly been keeping front line workers safer during the pandemic. For 2020 they expect to have produced 2 billion of the masks and continue to partner with the US Department of Defense. The automotive OEM business has struggled with sales down 44% during the pandemic, but analysts expect that to rebound and that could have a sizable impact to the bottom line. Their health care segment is expected to pick up as well, after seeing a 12% yoy slowdown, as delays in elective procedures are removed. It has an attractive yield that is backed by a payout ratio of 65% of cash flow. We like the technical breakout recently and look for this Top Pick to test $185. We would like to buy on a pullback to $160 -- looking for over 15% upside. Yield 3.47%
mngmnt / diversified
DON'T BUY
Not so high on this one. Trouble getting traction. Exposed to the global economy. Revenues for 2021 will be lower than in 2018. Profitability metrics are challenged. PFAS lawsuit is building steam, which could be as big as asbestos or lead in paint issues.
mngmnt / diversified
DON'T BUY
The shares broke down below some strong support and then bounced off one of his break points. It has only bounced back to its fair market value. The problem is that the fair market value and the earnings have been slipping for two years. It is not a COVID-19 issue. He does not think there is much in it for you.
mngmnt / diversified
BUY
You need more cash than debt for the dividend to be safe, in general. If you can get it for 3 to 5 years, you are holding a national champion. If you are fixed on just near term income, then perhaps it is not for you.
mngmnt / diversified
WAIT
Multi-dimensional company. Had a nice multiple and consistent earnings. In last little while, it's become more cyclical. Missed numbers, which is a makeup of their products. Earnings quality has fallen. Don't own it until you see more stability in company direction. You can own it cheaper. Decent yield of 3.6%.
mngmnt / diversified
DON'T BUY
It's an underperforming industrial stock that has stumbled in recent years. The nail in the coffin for him is that a carcinogenic chemical in many of its products is leading to lawsuits which he fears will accelerate.
mngmnt / diversified
DON'T BUY
It's had a rough 18 months, but remains a quality company. Activists may be trying to break up this company. It's not his favourite stock. Earnings came out today and they announced re-structuring charges, and they are in the middle of litigation about a chemical leaching into water. Pass. If you already own it, you probably have a big capital gain, or you can switch to Honeywell.
mngmnt / diversified
Showing 1 to 15 of 161 entries

3M Co.(MMM-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 3

Stockchase rating for 3M Co. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

3M Co.(MMM-N) Frequently Asked Questions

What is 3M Co. stock symbol?

3M Co. is a American stock, trading under the symbol MMM-N on the New York Stock Exchange (MMM). It is usually referred to as NYSE:MMM or MMM-N

Is 3M Co. a buy or a sell?

In the last year, 3 stock analysts published opinions about MMM-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for 3M Co..

Is 3M Co. a good investment or a top pick?

3M Co. was recommended as a Top Pick by on . Read the latest stock experts ratings for 3M Co..

Why is 3M Co. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is 3M Co. worth watching?

3 stock analysts on Stockchase covered 3M Co. In the last year. It is a trending stock that is worth watching.

What is 3M Co. stock price?

On 2022-01-26, 3M Co. (MMM-N) stock closed at a price of $169.3.